欢迎访问浙江中西医结合杂志   今天是   加入收藏   |   设为首页
王芳.前列舒畅汤保留灌肠佐治Ⅲ型前列腺炎的临床观察[J].浙江中西医结合杂志,2014,24(12):
前列舒畅汤保留灌肠佐治Ⅲ型前列腺炎的临床观察
Clinical Observation on Treating Category Ⅲ Prostatitis with Qianlieshuchang Decoction Retention Enema,Wang Fang,Jinhua Hospital of TCM affiliated to Zhejiang University of Traditional Chinese Medicine,Jinhua,321017,China
投稿时间:2014-04-23  修订日期:2014-05-11
DOI:
中文关键词:  Ⅲ型前列腺炎  保留灌肠  特拉唑嗪  左氧氟沙星
英文关键词:Category Ⅲ Prostatitis  Retention Enema  Terazosin  Levofloxacin
基金项目:
作者单位E-mail
王芳* 金华市中医医院 wangfang10698@163.com 
摘要点击次数: 927
全文下载次数: 0
中文摘要:
      【摘要】目的 观察中西医结合治疗Ⅲ型前列腺炎的疗效和安全性。方法 将86例Ⅲ型前列腺炎患者随机分为观察组和对照组。观察组患者在口服特拉唑嗪片、左氧氟沙星片的基础上联合中药保留灌肠,对照组患者口服特拉唑嗪片、左氧氟沙星片,共4周。采用慢性前列腺炎症状指数评分(NIH-CPSI)对症状及疗效进行评估和比较,并记录不良反应。结果 两组患者治疗后较治疗前NIH-CPSI评分有明显改善,观察组患者NIH-CPSI评分均优于对照组,差异均有统计学意义(P<0.05);观察组总有效率为89.5%高于对照组的72.5%,差异有统计学意义(P<0.05)。结论 中西医结合疗法可以安全有效治疗Ⅲ型前列腺炎,值得临床推广使用。
英文摘要:
      【Abstract】Objective To investigate the efficacy and safety of integrative medicine in the treatment of category Ⅲ prostatitis.Methods Total 86 patients with category Ⅲ prostatitis were randomly divided into observation group and control group.The patients of observation group were received qianlieshuchang decoction retention enema,terazosin and levofloxacin, and the patients of control group were received terazosin and levofloxacin.The course lasted 4 weeks. The NIH-CPSI and adverse events were evaluated, at begin and end of the trial. Results The NIH-CPSI of two groups were improved(P<0.05), and NIH-CPSI of observation group were better than that of control group(P<0.05).The effective rate in observation group and control group were separately 89.5% and 72.5%, and observation group dramatically better than control group,in which,the statistically has obviously difference(P<0.05). Conclusion It is effective and safe of integrative medicine in the treatment of category Ⅲ prostatitis,so it was worth more promoting in clinical application.
查看全文  查看/发表评论  下载PDF阅读器
关闭